MAP2K3 Protein (Transcript Variant A) (Myc-DYKDDDDK Tag)

N° du produit ABIN2725387

Détail du produit

Antigène: MAP2K3 (Mitogen-Activated Protein Kinase Kinase 3 (MAP2K3))

Type de proteíne: Recombinant

Attributs du protein: Transcript Variant A

Origine: Humain

Source: HEK-293 Cells

Purification/Conjugué: Cette MAP2K3 protéine est marqué à la Myc-DYKDDDDK Tag.

Application: Antibody Production (AbP), Standard (STD)

Attributs du produit:

• Recombinant human MAP2K3 (transcript variant A) protein expressed in HEK293 cells.
• Produced with end-sequenced ORF clone

Pureté: > 80 % as determined by SDS-PAGE and Coomassie blue staining

Information d'application

Indications d'application: Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays

Commentaires:

The tag is located at the C-terminal.

Restrictions: For Research Use only

Stockage

Concentration: 50 μg/mL

Buffer: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.

Stock: -80 °C

Stockage commentaire: Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.

Détail du antigène

Antigène: MAP2K3 (Mitogen-Activated Protein Kinase Kinase 3 (MAP2K3))

Autre désignation: Map2k3 (MAP2K3 Produits)

Synonymes: MAPKK3 Protein, MEK3 Protein, MKK3 Protein, PRKMK3 Protein, SAPKK-2 Protein, SAPKK2 Protein, AW212142 Protein, Prkmk3 Protein, mMKK3b Protein, Mkk3 Protein, mitogen-activated protein kinase kinase 3 Protein, mitogen activated protein kinase kinase 3 Protein, MAP kinase activator XMEK3 Protein, MAP2K3 Protein, Map2k3 Protein, map2k3 Protein

Sujet: The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is activated by mitogenic and environmental stress, and participates in the MAP kinase-mediated signaling cascade. It phosphorylates and thus activates MAPK14/p38-MAPK. This kinase can be activated by insulin, and is necessary for the expression of glucose transporter. Expression of RAS oncogene is found to result in the accumulation of the active form of this kinase, which thus leads to the constitutive activation of MAPK14, and confers oncogenic transformation of primary cells. The inhibition of this kinase is involved in the pathogenesis of Yersina pseudotuberculosis. Multiple alternatively spliced transcript variants that encode distinct isoforms have been reported for this gene.

Poids moléculaire: 36 kDa

NCBI Accession: NP_002747

Pathways: Signalisation MAPK, Signalisation TLR, Activation of Innate immune Response, Toll-Like Receptors Cascades, Autophagy, Signaling Events mediated by VEGFR1 and VEGFR2